Long-term benefit of high-dose epirubicin in adjuvant chemotherapy for node-positive breast cancer: 15-year efficacy results of the Belgian multicentre study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples